- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 19, 2024, 07:02:10 AM
- Local Time:
- June 02, 2024, 11:19:07 AM
- Last Active:
- May 19, 2024, 12:31:45 PM
Signature:
Outcomes Juglone restricted the development rate associated with OVCAR-3 ovarian cancer malignancy cells and also confirmed a great IC50 of Thirty